Figure 1: PLS-DA three-dimensional score plots and validation plots for the metabolic profiling results.
From: A Comprehensive Analysis of Metabolomics and Transcriptomics in Cervical Cancer
(a) PLS-DA three-dimensional score plot for CC versus NOR in the ESI+ mode (three latent variables, R2X = 0.211, R2Y = 0.924, Q2 = 0.878). (b) Validation plot for CC versus NOR in ESI+ mode. (c) PLS-DA three-dimensional score plot for CC versus NOR in the ESI- mode (three latent variables, R2X = 0.297, R2Y = 0.917, Q2 = 0.896). (d) Validation plot for CC versus NOR in ESI- mode. The criteria for stability and credibility are as follows: all permuted R2 and Q2 values on the left are lower than the original point on the right, and the Q2 regression line in blue has a negative intercept.
